This week, we are taking a look at an important subject, and that is women working as CEOs, or other senior roles, in the biotech space. Kate Yen is the CEO of oncology biotech Auron Therapeutics, and she has spent her entire career in science. Auron is working on the next generation of targeted cancer therapies by identifying and inhibiting the oncogenic cell states of cancer. Auron’s AURIGIN platform uses AI and machine learning to compare normal cell states with cancerous cell st...
Podden och tillhörande omslagsbild på den här sidan tillhör Labiotech. Innehållet i podden är skapat av Labiotech och inte av, eller tillsammans med, Poddtoppen.